Aster Pharmacy collaborates with Dr. Reddy's to market its high-quality medicines in UAE and GCC

Aster Pharmacy, the retail arm of Aster DM Healthcare and a leading pharmacy chain in the GCC, and Dr. Reddy's laboratories India Ltd, a global pharmaceutical firm headquartered in Hyderabad, India, have signed a memorandum of understanding to make affordable and high-quality medication more widely available in the region. Dr. Reddy's will manufacture and supply certain medications in the identified therapy areas to Alfa One, Aster Pharmacy's marketing and distribution arm, under the terms of the agreement. Alfa One will distribute the drugs throughout the UAE and the GCC.

The agreement was signed this year at Arab Health, a global healthcare exhibition held in Dubai. "Aster believes in bringing the best medical care to the people we serve through our healthcare services and products," said Dr. Azad Moopen, Founder Chairman and Managing Director, Aster DM Healthcare. Because medicines play such an important role in providing high-quality healthcare at an affordable price, we believe that collaborating with reputable pharmaceutical manufacturers will be extremely beneficial. The collaboration with renowned Indian pharmaceutical major Dr. Reddy's Lab is an important step towards making branded generics of international renown available in the GCC region." "At Aster, we serve nearly 20 million patients each year, and our goal is to provide the best care possible based on their needs. As a result, our strategy is centred on innovation, diversification, and ensuring affordable access to the best healthcare solutions. Aster Pharmacy was founded more than two decades ago and is constantly expanding its footprint and product portfolio to meet our customers' needs.

With Dr. Reddy's diverse product offerings and expertise in generics, we believe this collaboration will strengthen the region's healthcare sector," said Ms. Alisha Moopen, Deputy Managing Director, Aster DM Healthcare. Deepak Sapra, CEO – API & Services, Dr. Reddy’s Laboratories India Ltd said: “We have had a close business relationship with the UAE and GCC. We value this opportunity to serve more patients in the region with our high-quality and trusted products. As a vertically integrated company, Dr. Reddy’s will manufacture the active pharmaceutical ingredient (API) as well as the formulation in-house at its facilities.

The APIs will be manufactured at facilities approved by the regulatory authorities of the U.S., Europe and other highly-regulated markets. By combining our manufacturing strengths with the marketing and distribution strengths of a strong partner such as Aster, we will be able to take strides towards our goal of reaching over 1.5 billion patients by 2030.” Aster DM Healthcare currently operates 245 pharmacies in GCC. Today, Aster Pharmacy markets 85 brands of local and international repute and has emerged as the brand of choice amongst pharmacies due to its ease of access and customer first approach.